Capabilities
Market research and commercial support to guide strategic decisions
As the global healthcare industry becomes more complex, successfully navigating access and policy challenges is critical to delivering therapies to patients. At Medicus, we rely on deep industry experience, innovative market research, and hands-on commercial support to guide policy and access decisions for our clients.
Access Strategy & Policy
Medicus helps clients generate and analyze information needed for strategic decisions. Our data-driven approach helps clients understand key market trends, reimbursement and access hurdles, and evidence needs.
01.
In-depth interviews with payers, providers, and patients to develop and test value messages
Patient journey analyses to assess the current treatment landscape
Market sizing and segmentation to inform market opportunities
02.
Review evidence needs to support product value messages
Generate early-stage models and targeted literature reviews to identify evidence gaps
Develop evidence generation roadmaps to guide strategic data planning
03.
Analogue research to assess price and market access strategies for comparable products
Health economic modeling to support pricing decisions and communication
Analytical modeling to support outcomes-based contracting and risk assessments
04.
Patient support program (PSP) development to ensure successful and compliant patient support
Distribution channel research
Hands-on field team support and analytics
05.
Generation of AMCP and global value dossiers to support value communication
Publication and dissemination of policy research to advance thought leadership
Review and critique of recommendations from value assessment bodies (e.g., ICER, NICE)
Access Strategy & Policy in Context
From pre-launch planning to patient support, Medicus provides pricing, access, and policy support throughout the product life cycle.
At the intersection of healthcare economics and market access, Medicus helps clients understand the value of their therapies in an ever-changing treatment landscape. We review existing evidence, conduct novel analyses to fill gaps, and use primary research to test hypotheses with economic decision-makers.
To optimize success for new therapies, manufacturers often need to generate novel data and fill evidence gaps. We partner with clients to identify, prioritize, and plan evidence generation efforts throughout the product life cycle to make sure that value is not left on the table.
As novel products reach the market, manufacturers face challenging decisions related to product pricing and market access. We conduct innovative quantitative and qualitative market research to reduce uncertainty for our clients and inform strategic decisions.
As treatment decisions become more complex, it is essential that manufacturers effectively communicate the value of their therapies to diverse stakeholders. We help our clients communicate the value of their products through economic value dossiers, peer-reviewed publications, and market research presented at industry conferences.
Case Studies
Explore case studies with a focus on Access Strategy & Policy
Capabilities
Learn more about our other practice areas